BCLI - BrainStorm Cell Therapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BCLI - BrainStorm Cell Therapeutics Inc.

BCLI 0.680

+4.6%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: midastouch017	2/27/2006 10:29:56 AM
	of 288

BrainStorm's Stem Cell Hospital Partnering Gets Media Coverage Monday February 27, 9:17 am ET NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Feb. 27, 2006--BrainStorm Cell Therapeutics (OTCBB: BCLI - News), the developer of NurOwn(TM) bone marrow derived stem cell therapeutic products for the treatment of neurodegenerative diseases, announced today that a cover story article about BrainStorm appears in the Vol.6 Issue 1 edition of BioIsrael, a magazine covering Israeli biotechnology. The article is titled "Stem Cells Bring New Business Models: BrainStorm Beefs Up Revenue-Sharing With Hospitals" and includes an interview with Yoram Drucker, Chief Operations Officer and Principal Executive of BrainStorm. The article may be viewed at www.bioisrael.com Brainstorm recently announced that it had successfully used its stem cell technology to derive olgodendrocyte-like cells as a potential therapy for Multiple Sclerosis. In other studies, Brainstorm has successfully used bone marrow stem cells to produce dopaminergic-like cells shown to be capable of dopamine secretion and to benefit animal models of Parkinson's disease. Brainstorm also has used its bone marrow stem cell technology to produce astrocyte-like cells with the capacity of producing glial derived neurotrophic factor (GDNF), the most potent neurotrophic factor known for dopaminergic neurons . Transplanted dopamine- and GDNF producing-cells, acting on their own or in combination, hold great promise for replacement and preservation of neurons in Parkinson's and other neurodegenerative diseases. biz.yahoo.com Dubi

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next